Clinical Trials Logo

Clinical Trial Summary

New data suggests that the current treatment for pediatric adamantinomatous craniopharyngioma (CPA) may not be as effective as it could be.


Clinical Trial Description

Current treatment regimens for pediatric CPA are limited to surgery and radiation therapy. This pilot study seeks to identify biologically rational therapeutics for the medical treatment of adamantinomatous CPA by confirming the overexpression of specific molecules. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03610906
Study type Observational
Source University of Colorado, Denver
Contact
Status Enrolling by invitation
Phase
Start date March 12, 2019
Completion date December 2030

See also
  Status Clinical Trial Phase
Recruiting NCT05465174 - Nivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults Phase 2